Cindy Marando

1.2k total citations
7 papers, 300 citations indexed

About

Cindy Marando is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Cindy Marando has authored 7 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pathology and Forensic Medicine and 2 papers in Molecular Biology. Recurrent topics in Cindy Marando's work include Cancer Mechanisms and Therapy (2 papers), Peptidase Inhibition and Analysis (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Cindy Marando is often cited by papers focused on Cancer Mechanisms and Therapy (2 papers), Peptidase Inhibition and Analysis (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Cindy Marando collaborates with scholars based in United States. Cindy Marando's co-authors include Gengjie Yang, Jin‐Cong Zhuo, Wenqing Yao, Jordan S. Fridman, Robert Newton, Peggy Scherle, Xiangdong Liu, Qian Wang, Sharon Diamond and Richard Wynn and has published in prestigious journals such as Clinical Cancer Research, The Journal of Pediatrics and Breast Cancer Research.

In The Last Decade

Cindy Marando

7 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cindy Marando United States	5	151	116	101	76	64	7	300
Arsène‐Bienvenu Loembé United Kingdom	9	196 1.3×	168 1.4×	88 0.9×	100 1.3×	42 0.7×	15	377
Jayne Gurtler United States	7	188 1.2×	68 0.6×	120 1.2×	98 1.3×	82 1.3×	14	332
Fa-Chyi Lee United States	9	193 1.3×	124 1.1×	85 0.8×	156 2.1×	79 1.2×	24	385
Tao Osgood United States	6	185 1.2×	158 1.4×	51 0.5×	58 0.8×	32 0.5×	14	308
Eisuke Kurihara Japan	8	148 1.0×	110 0.9×	38 0.4×	113 1.5×	32 0.5×	12	271
Susanne Hedbom Germany	4	277 1.8×	167 1.4×	82 0.8×	120 1.6×	47 0.7×	5	463
Xiao-Dong Zhu China	10	130 0.9×	155 1.3×	90 0.9×	83 1.1×	64 1.0×	14	375
Meaghan Dendy United States	8	105 0.7×	200 1.7×	89 0.9×	60 0.8×	38 0.6×	11	345
Xuejing Aimee Wang United States	8	126 0.8×	131 1.1×	116 1.1×	161 2.1×	40 0.6×	15	294
Rodrigo Ruiz-Soto United States	9	186 1.2×	174 1.5×	36 0.4×	90 1.2×	92 1.4×	19	408

Countries citing papers authored by Cindy Marando

Since Specialization

Citations

This map shows the geographic impact of Cindy Marando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy Marando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy Marando more than expected).

Fields of papers citing papers by Cindy Marando

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy Marando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy Marando. The network helps show where Cindy Marando may publish in the future.

Co-authorship network of co-authors of Cindy Marando

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy Marando. A scholar is included among the top collaborators of Cindy Marando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy Marando. Cindy Marando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Patel, Manish R., William B. Donnellan, Michael Byrne, et al.. (2023). Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies. Clinical Lymphoma Myeloma & Leukemia. 23(9). 674–686. 4 indexed citations

Liu, Xiangdong, Qian Wang, Gengjie Yang, et al.. (2011). A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3. Clinical Cancer Research. 17(22). 7127–7138. 190 indexed citations

Burns, David, Yunlong Li, Eric Shi, et al.. (2009). Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition. Bioorganic & Medicinal Chemistry Letters. 19(13). 3525–3530. 4 indexed citations

Burns, David, Chunhong He, Yanlong Li, et al.. (2007). Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1′ permutations. Bioorganic & Medicinal Chemistry Letters. 18(2). 560–564. 13 indexed citations

Perkins, R. Serene, Cindy Marando, Diana Dickson-Witmer, et al.. (2006). Analysis of Epstein-Barr virus reservoirs in paired blood and breast cancer primary biopsy specimens by real time PCR. Breast Cancer Research. 8(6). R70–R70. 38 indexed citations

Liu, Xiangdong, Jordan S. Fridman, Qian Wang, et al.. (2006). Selective inhibition of ADAM metalloproteases blocks HER-2 extracellular domain (ECD) cleavage and potentiates the anti-tumor effects of trastuzumab. Cancer Biology & Therapy. 5(6). 648–656. 45 indexed citations

Dunn, Stephen P., Anthony Tsai, Gregory Griffin, et al.. (2005). Liver transplantation as definitive treatment for a factor V Leiden mutation. The Journal of Pediatrics. 146(3). 418–422. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact